Awareness of and attitude toward COVID-19 vaccination among individuals with COPD and the strategies to overcome vaccine hesitation: A mini review

References

• Organization WH. Evidence-informed policy network: EVIPnet in action; [ accessed 2021 Nov 10]. http://www.who.int/evidence.
   Google Scholar
• Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, global initiative for chronic obstructive lung disease (GOLD) 2021 report; [accessed 2021 Jan 15]. http://www.goldcopd.org/.
   Google Scholar
• Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, Quaderi S, Mandal S, Hurst JR. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis. PLoS ONE. 2020;15(5):e0233147. doi:10.1371/journal.pone.0233147.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Liang WH, Zhao Y, Liang H-R, Chen Z-S, Li Y-M, Liu X-Q, Chen R-C, Tang C-L, Wang T, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. doi:10.1183/13993003.00547-2020.
   PubMed Web of Science ®Google Scholar
• Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(6):803–7. doi:10.1016/S1473-3099(20)30987-7.
   PubMed Web of Science ®Google Scholar
• Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021;397(10275):671–81. doi:10.1016/S0140-6736(21)00234-8.
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–16. doi:10.1056/NEJMoa2035389.
   PubMed Web of Science ®Google Scholar
• Adu P, Poopola T, Medvedev ON, Collings S, Mbinta J, Aspin C, Simpson CR. Implications for COVID-19 vaccine uptake: a systematic review. J Infect Public Health. 2023;16(3):441–66. doi:10.1016/j.jiph.2023.01.020.
   PubMed Web of Science ®Google Scholar
• Song Z, Liu X, Xiang P, Lin Y, Dai L, Guo Y, Liao J, Chen Y, Liang Y, Sun Y, et al. The Current status of vaccine uptake and the impact of COVID-19 on intention to vaccination in patients with COPD in Beijing. Int J Chron Obstruct Pulmon Dis. 2021;16:3337–46. doi:10.2147/COPD.S340730.
   PubMed Web of Science ®Google Scholar
• Leung JM, Yang CX, Tam A, Shaipanich T, Hackett T-L, Singhera GK, Dorscheid DR, Sin DD. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020;55(5):2000688. doi:10.1183/13993003.00688-2020.
   PubMed Web of Science ®Google Scholar
• Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19). J Clin Med. 2020;9(3): doi:10.3390/jcm9030841.
   PubMed Web of Science ®Google Scholar
• Southworth T, Jackson N, Singh D. Airway immune responses to COVID-19 vaccination in COPD patients and healthy subjects. Eur Respir J. 2022;60(2): doi:10.1183/13993003.00497-2022.
   PubMed Web of Science ®Google Scholar
• Thompson MG, Stenehjem E, Grannis S, Ball SW, Naleway AL, Ong TC, DeSilva MB, Natarajan K, Bozio CH, Lewis N, et al. Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings. N Engl J Med. 2021;385(15):1355–71. doi:10.1056/NEJMoa2110362.
   PubMed Web of Science ®Google Scholar
• Kwok WC, Leung S, Tam T, Ho JCM, Lam DCL, Ip MSM, Ho PL. Efficacy of mRNA and inactivated whole virus vaccines against COVID-19 in patients with chronic respiratory diseases. Int J Chron Obstruct Pulmon Dis. 2023;18:47–56. doi:10.2147/COPD.S394101.
   PubMed Web of Science ®Google Scholar
• Lv G, Yuan J, Xiong X, Li M. Mortality rate and characteristics of deaths following COVID-19 vaccination. Front Med. 2021;8:670370. doi:10.3389/fmed.2021.670370.
   Web of Science ®Google Scholar
• Huang HH, Chen SJ, Chao TF, Liu C-J, Chen T-J, Chou P, Wang F-D. Influenza vaccination and risk of respiratory failure in patients with chronic obstructive pulmonary disease: a nationwide population-based case-cohort study. J Microbiol, Immunol Infect. 2019;52(1):22–9. doi:10.1016/j.jmii.2017.08.014.
   PubMedGoogle Scholar
• Joseph C, Elgohari S, Nichols T, Verlander N. Influenza vaccine uptake in adults aged 50–64 years: policy and practice in England 2003/2004. Vaccine. 2006;24(11):1786–91. doi:10.1016/j.vaccine.2005.10.024.
   PubMed Web of Science ®Google Scholar
• Hara M, Sakamoto T, Tanaka K. Influenza vaccine effectiveness among elderly persons living in the community during the 2003–2004 season. Vaccine. 2008;26(50):6477–80. doi:10.1016/j.vaccine.2008.06.035.
   PubMed Web of Science ®Google Scholar
• Kwong EW, Lam IO, Chan TM. What factors affect influenza vaccine uptake among community-dwelling older Chinese people in Hong Kong general outpatient clinics. J Clin Nurs. 2009;18(7):960–71. doi:10.1111/j.1365-2702.2008.02548.x.
   PubMed Web of Science ®Google Scholar
• Crawshaw AF, Farah Y, Deal A, Rustage K, Hayward SE, Carter J, Knights F, Goldsmith LP, Campos-Matos I, Wurie F, et al. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. Lancet Infect Dis. 2022;22(9):e254–e66. doi:10.1016/S1473-3099(22)00066-4.
   PubMed Web of Science ®Google Scholar
• Peters M. Addressing vaccine hesitancy and resistance for COVID-19 vaccines. Int J Nurs Stud. 2022;131:104241. doi:10.1016/j.ijnurstu.2022.104241.
   PubMed Web of Science ®Google Scholar
• Adella GA, Abebe K, Atnafu N, Azeze GA, Alene T, Molla S, Ambaw G, Amera T, Yosef A, Eshetu K, et al. Knowledge, attitude, and intention to accept COVID-19 vaccine among patients with chronic diseases in southern Ethiopia: multi-center study. Front Public Health. 2022;10:917925. doi:10.3389/fpubh.2022.917925.
   PubMed Web of Science ®Google Scholar
• Fekete M, Horvath A, Santa B, Tomisa G, Szollosi G, Ungvari Z, Fazekas-Pongor V, Major D, Tarantini S, Varga JT. COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease – a cross-sectional study in Hungary. Vaccine. 2023;41(1):193–200. doi:10.1016/j.vaccine.2022.11.020.
   PubMed Web of Science ®Google Scholar
• Rosenblum HG, Gee J, Liu R, Marquez PL, Zhang B, Strid P, Abara WE, McNeil MM, Myers TR, Hause AM, et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the vaccine adverse event reporting system and v-safe. Lancet Infect Dis. 2022;22:802–12. doi:10.1016/S1473-3099(22)00054-8.
   PubMed Web of Science ®Google Scholar
• Hause AM, Baggs J, Marquez P, Myers TR, Su JR, Blanc PG, Gwira Baumblatt JA, Woo EJ, Gee J, Shimabukuro TT, et al. Safety monitoring of COVID-19 vaccine booster doses among adults — United States, September 22, 2021–February 6, 2022. Morb Mortal Wkly Rep. 2022;71(7):249–54. doi:10.15585/mmwr.mm7107e1.
   PubMed Web of Science ®Google Scholar
• Munro A, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dodd K, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet. 2021;398:2258–76. doi:10.1016/S0140-6736(21)02717-3.
   PubMed Web of Science ®Google Scholar
• Belingheri M, Roncalli M, Riva MA, Paladino ME, Teruzzi CM. COVID-19 vaccine hesitancy and reasons for or against adherence among dentists. J Am Dent Assoc. 2021;152(9):740–6. doi:10.1016/j.adaj.2021.04.020.
   PubMed Web of Science ®Google Scholar
• Burke PF, Masters D, Massey G. Enablers and barriers to COVID-19 vaccine uptake: an international study of perceptions and intentions. Vaccine. 2021;39(36):5116–28. doi:10.1016/j.vaccine.2021.07.056.
   PubMed Web of Science ®Google Scholar
• Alibrahim J, Awad A. COVID-19 vaccine hesitancy among the public in Kuwait: a cross-sectional survey. Int J Environ Res Public Health. 2021;18(16):8836. doi:10.3390/ijerph18168836.
   PubMed Web of Science ®Google Scholar
• Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46:270–7. doi:10.1007/s10900-020-00958-x.
   PubMed Web of Science ®Google Scholar
• Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, Dias S, Leite A, Nunes C. Factors associated with COVID-19 vaccine hesitancy. Vaccines (Basel). 2021;9(3): doi:10.3390/vaccines9030300.
   Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C, Kang J, Ran P, Shen H, Wen F, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–17. doi:10.1016/S0140-6736(18)30841-9.
   PubMed Web of Science ®Google Scholar
• Callaghan T, Moghtaderi A, Lueck JA, Hotez P, Strych U, Dor A, Fowler EF, Motta M. Correlates and disparities of intention to vaccinate against COVID-19. Social Sci Med. 2021;272:113638. doi:10.1016/j.socscimed.2020.113638.
   PubMed Web of Science ®Google Scholar
• Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. Adults. Ann Intern Med. 2020;173:964–73. doi:10.7326/M20-3569.
   PubMed Web of Science ®Google Scholar
• Nguyen TC, Gathecha E, Kauffman R, Wright S, Harris CM. Healthcare distrust among hospitalised black patients during the COVID-19 pandemic. Postgrad Med J. 2022;98:539–43. doi:10.1136/postgradmedj-2021-140824.
   PubMed Web of Science ®Google Scholar
• Walker KK, Head KJ, Owens H, Zimet GD. A qualitative study exploring the relationship between mothers’ vaccine hesitancy and health beliefs with COVID-19 vaccination intention and prevention during the early pandemic months. Hum Vaccin Immunother. 2021;17:3355–64. doi:10.1080/21645515.2021.1942713.
   PubMed Web of Science ®Google Scholar
• Ohlsen EC, Yankey D, Pezzi C, Kriss JL, Lu PJ, Hung MC, Bernabe M, Kumar GS, Jentes E, Elam-Evans LD, et al. Coronavirus disease 2019 (COVID-19) vaccination coverage, intentions, attitudes, and barriers by race/ethnicity, language of interview, and nativity—national immunization survey adult COVID module, 22 April 2021–29 January 2022. Clin Infect Dis. 2022;75(Supplement_2):S182–S92. doi:10.1093/cid/ciac508.
   PubMedGoogle Scholar
• Dubé È, Ward JK, Verger P, MacDonald NE. Vaccine hesitancy, acceptance, and anti-vaccination: trends and future prospects for public health. Annu Rev Public Health. 2021;42:175–91. doi:10.1146/annurev-publhealth-090419-102240.
   PubMed Web of Science ®Google Scholar
• Mobarak AM, Miguel E, Abaluck J, Ahuja A, Alsan M, Banerjee A, Breza E, Chandrasekhar AG, Duflo E, Dzansi J, et al. End COVID-19 in low- and middle-income countries. Science. 2022;375(6585):1105–10. doi:10.1126/science.abo4089.
   PubMed Web of Science ®Google Scholar
• Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–58. doi:10.1016/S2213-2600(21)00511-7.
   PubMed Web of Science ®Google Scholar
• Pertwee E, Simas C, Larson HJ. An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy. Nat Med. 2022;28:456–9. doi:10.1038/s41591-022-01728-z.
   PubMed Web of Science ®Google Scholar
• Coustasse A, Kimble C, Maxik K. COVID-19 and vaccine hesitancy: a challenge the United States must overcome. J Ambul Care Manage. 2021;44:71–5. doi:10.1097/JAC.0000000000000360.
   PubMed Web of Science ®Google Scholar
• Zhu KW. Why is it necessary to improve COVID-19 vaccination coverage in older people? How to improve the vaccination coverage. Hum Vaccin Immunother. 2023;19(2):2229704. doi:10.1080/21645515.2023.2229704.
   PubMed Web of Science ®Google Scholar
• Santos-Sancho JM, Jimenez-Trujillo I, Hernández-Barrera V, López-de Andrés A, Carrasco-Garrido P, Ortega-Molina P, Jiménez-García R. Influenza vaccination coverage and uptake predictors among Spanish adults suffering COPD. Hum Vaccin Immunother. 2012;8(7):938–45. doi:10.4161/hv.20204.
   PubMed Web of Science ®Google Scholar
• Yeung MP, Lam FL, Coker R. Factors associated with the uptake of seasonal influenza vaccination in adults: a systematic review. J Public Health (Oxf). 2016;38(4):746–53. doi:10.1093/pubmed/fdv194.
   PubMed Web of Science ®Google Scholar
• Li A, Chan YH, Liew MF, Pandey R, Phua J. Improving influenza vaccination coverage among patients with COPD: a pilot project. Int J Chron Obstruct Pulmon Dis. 2019;14:2527–33. doi:10.2147/COPD.S222524.
   PubMed Web of Science ®Google Scholar
• Bazargan M, Wisseh C, Adinkrah E, Ameli H, Santana D, Cobb S, Assari S. Influenza vaccination among underserved African-American older adults. Biomed Res Int. 2020;2020:1–9. doi:10.1155/2020/2160894.
   Web of Science ®Google Scholar
• Chen X, Lee W, Lin F. Infodemic, institutional trust, and COVID-19 vaccine hesitancy: a cross-national survey. Int J Environ Res Public Health. 2022;19(13): doi:10.3390/ijerph19138033.
   Web of Science ®Google Scholar
• Ramot S, Tal O. Supporting healthcare workers in vaccination efforts. Hum Vaccin Immunother. 2023;19(1):2172882. doi:10.1080/21645515.2023.2172882.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Muscatello DJ, Wang Q, Yang P, Wu J, MacIntyre CR. Overview of influenza vaccination policy in Beijing, China: current status and future prospects. J Public Health Policy. 2017;38(3):366–79. doi:10.1057/s41271-017-0079-7.
   PubMed Web of Science ®Google Scholar
• Schumacher S, Salmanton-García J, Cornely OA, Mellinghoff SC. Increasing influenza vaccination coverage in healthcare workers: a review on campaign strategies and their effect. Infection. 2021;49(3):387–99. doi:10.1007/s15010-020-01555-9.
   PubMed Web of Science ®Google Scholar
• Sadique MZ. Individual freedom versus collective responsibility: an economic epidemiology perspective. Emerg Themes Epidemiol. 2006;3:12. doi:10.1186/1742-7622-3-12.
   PubMedGoogle Scholar